BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28535651)

  • 1. [Study of susceptibility weighted imaging on MR and pathologic findings to distinguish benign or malignant soft tissue tumor].
    Liu J; Chen Y; Bao XM; Ling XL; Ding JP; Zhang ZK
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):350-354. PubMed ID: 28535651
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
    Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
    BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC; Watkins TW; Kwan GN; Haacke EM
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft-tissue tumors of the foot: value of MR imaging for specific diagnosis.
    Wetzel LH; Levine E
    AJR Am J Roentgenol; 1990 Nov; 155(5):1025-30. PubMed ID: 2120930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue tumors? A study of the French sarcoma group.
    Crombé A; Brisse HJ; Ledoux P; Haddag-Miliani L; Bouhamama A; Taieb S; Le Loarer F; Kind M
    Eur Radiol; 2019 Jun; 29(6):3170-3182. PubMed ID: 30560359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
    Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
    Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of susceptibility-weighted imaging and intratumoral susceptibility signals in grading and differentiating pediatric brain tumors at 1.5 T: a preliminary study.
    Gaudino S; Marziali G; Pezzullo G; Guadalupi P; Giordano C; Infante A; Benenati M; Ramaglia A; Massimi L; Gessi M; Frassanito P; Caldarelli M; Colosimo C
    Neuroradiology; 2020 Jun; 62(6):705-713. PubMed ID: 32140783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of Diffusion-Weighted Imaging Combined with Susceptibility-Weighted Imaging in Differentiating Benign from Malignant Parotid Gland Lesions.
    Zhang W; Zuo Z; Huang X; Jin G; Su D
    Med Sci Monit; 2018 Jul; 24():4610-4616. PubMed ID: 29972148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
    Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
    AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity.
    Chung WJ; Chung HW; Shin MJ; Lee SH; Lee MH; Lee JS; Kim MJ; Lee WK
    Br J Radiol; 2012 Oct; 85(1018):e831-6. PubMed ID: 22553293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones?
    Crim JR; Seeger LL; Yao L; Chandnani V; Eckardt JJ
    Radiology; 1992 Nov; 185(2):581-6. PubMed ID: 1410377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinicopathological characteristics and prognostic factors of foot and ankle soft tissue and bone tumors].
    Zhang XX; Xu LB; Xu SF; Zhao ZG; Liu T; Zhang SG; Yu SJ
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):685-689. PubMed ID: 30293395
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of MR findings in predicting the nature of the soft tissue lesions: benign, malignant or undetermined lesion?
    Soler R; Castro JM; Rodríguez E
    Comput Med Imaging Graph; 1996; 20(3):163-9. PubMed ID: 8930469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft tissue masses with myxoid stroma: Can conventional magnetic resonance imaging differentiate benign from malignant tumors?
    Crombe A; Alberti N; Stoeckle E; Brouste V; Buy X; Coindre JM; Kind M
    Eur J Radiol; 2016 Oct; 85(10):1875-1882. PubMed ID: 27666630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of MRI features to histopathologic grade of soft tissue sarcoma].
    Liu QY; Li HG; Chen JY; Liang BL
    Ai Zheng; 2008 Aug; 27(8):856-60. PubMed ID: 18710621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations of ITSS-Morphology and their Relationship to Location and Tumor Volume in Patients with Glioblastoma.
    Fahrendorf D; Hesselmann V; Schwindt W; Wölfer J; Jeibmann A; Kooijman H; Kugel H; Heindel W; Bink A
    J Neuroimaging; 2015; 25(6):1015-22. PubMed ID: 25703027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
    Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High intratumoral susceptibility signal grade on susceptibility-weighted imaging: a risk factor for hemorrhage after stereotactic biopsy.
    Tanji M; Mineharu Y; Sakata A; Okuchi S; Fushimi Y; Oishi M; Terada Y; Sano N; Yamao Y; Arakawa Y; Yoshida K; Miyamoto S
    J Neurosurg; 2023 Jan; 138(1):120-127. PubMed ID: 35561695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.